← Back to all trials
Enrolling By Invitation
NCT07216508
Liver Transplant CGM
Conditions: Liver Transplant, Post Transplant Diabetes, Type 2 Diabetes
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 40
Sponsor: Icahn School of Medicine at Mount Sinai
Location: Mount Sinai Hospital New York New York
Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Eligibility Criteria
Inclusion Criteria:
• inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL
Exclusion Criteria:
* having a planned discharge to a rehabilitation or nursing facility,
* a contraindication to sensor placement,
* if discharge is anticipated to be \>30 days post-transplant, or
* if recent transplant also included a kidney or pancreas transplant
Source: ClinicalTrials.gov (NCT07216508). StuddyBuddy aggregates publicly available trial information.
